by defeatmsa | Jun 30, 2021 | Medical Research
Defeat MSA Alliance Board of Directors is pleased to report some good news from Alterity Therapeutics on ATH434, a new drug being developed by the company for the treatment of Multiple System Atrophy. “Alterity is on track to launch the Phase 2 trial of...
by defeatmsa | Jun 11, 2021 | Advocacy Blog, Advocate's Blog
JUNE 11, 2021 FOR IMMEDIATE RELEASE: Defeat MSA Alliance and MSA United International Consortium is pleased to announce the publication of “The Truly Fantastic Adventures of the MSA Warriors” – America’s first illustrated storybook about our...
by defeatmsa | Jun 11, 2021 | Medical Research
JUNE 1, 2021 Defeat MSA Alliance Research Program Advisors: Important Questions & Answers from Biohaven RE: Clinical Trial on Verdiperstat Can I still join the trial? Answer: Enrollment for the phase 3 study closed in July of 2020. When are we expected...
Recent Comments